2007-07-04T00:00:00
Pharmaceutical company Janssen-Cilag has announced the authorisation of Invega (paliperidone), a new treatment for schizophrenia.
With a HSJ subscription you’ll unlock:
HSJ is part of Wilmington Healthcare Limited. Company number 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 30158470
Site powered by Webvision Cloud